A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya)

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Eye Disorder
Wet Age-Related Macular Degeneration

Results
Download
Print

Study results

LPS GR40306 TENAYA Final Results June 2022 English (PDF, 0.8 MB)

LPS GR40306 TENAYA Final Results June 2022 Hungarian Hungary (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya)

Study results

LPS GR40306 TENAYA Final Results June 2022 English (PDF, 0.8 MB)

LPS GR40306 TENAYA Final Results June 2022 Hungarian Hungary (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya)

For the latest version of this information please go to www.forpatients.roche.com